SCHEMBL7963695

SCHEMBL7963695

O=C(O)c1cccc(C2CCC=C(c3nc(-c4ccccc4)c(-c4ccccc4)o3)C2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 5/20 0.54
PTGIR P43119 4/20 0.54
PTGER1 P34995 1/20 0.54
KMO O15229 1/20 0.42
NR4A2 P43354 7/20 0.40
RXRA P19793 3/20 0.39
RXRB P28702 3/20 0.39
RXRG P48443 2/20 0.39
PTGER3 P43115 1/20 0.39
FABP4 P15090 2/20 0.38
KDM4E B2RXH2 5/20 0.37
ALDH1A1 P00352 3/20 0.37
HPGD P15428 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 1/20 0.37
GAA P10253 1/20 0.37
RAB9A P51151 1/20 0.37
FABP3 P05413 1/20 0.37
CYP3A4 P08684 2/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7959297 0.90 PTGER4 (0.44) PTGER4PTGIRPTGER1NR4A2RXRA
SCHEMBL7960009 0.82 TDP1 (0.42) PTGER4PTGIRPTGER1RXRARXRB
SCHEMBL7961262 0.82 PTGIR (0.66) PTGER4PTGIRPTGER1NR4A2PTGER3
SCHEMBL7957666 0.78 PTGER4 (0.52) PTGER4PTGIRPTGER1KMONR4A2
SCHEMBL7949886 0.73 PTGIR (0.89) PTGER4PTGIRPTGER1NR4A2PTGER3
SCHEMBL7958123 0.73 PTGIR (0.89) PTGER4PTGIRPTGER1NR4A2PTGER3
SCHEMBL7959822 0.72 PTGIR (0.54) PTGER4PTGIRPTGER1PTGER3FABP4
SCHEMBL7959285 0.72 PTGIR (0.83) PTGER4PTGIRPTGER1NR4A2PTGER3
SCHEMBL7960373 0.71 PTGIR (0.59) PTGER4PTGIRPTGER1NR4A2RXRA
SCHEMBL1626140 0.70 PTGIR (1.00) PTGER4PTGIRPTGER1NR4A2PTGER3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6245790-B1 ANTIINFLAMMATORY AGENTS; GASTROINTESTINAL DISORDERS; SKN DISORDERS; BONE DISORDERS; MUSCLE RELAXANTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-06-12 US disclosed
EP-0989975-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-05 EP disclosed
WO-2000016760-A2 NEW USE OF PROSTAGLANDIN E2 ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-03-30 WO disclosed
WO-1998055468-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-10 WO disclosed